Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hemodynamic Effects of Inhaled Milrinone versus Inhaled Nitroglycerin
PACTR202106565996138Completed
- Sponsor
- Ain Shams University
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of milrinone and nitroglycerin in pulmonary hypertension (PH) and mitral valve disease (2 arms), sponsored by Ain Shams University. Primary endpoint: Hemodynamic parameters. Started May 2021; status: completed.
02
Drugs
milrinonenitroglycerin
03
Conditions
pulmonary hypertension (PH)mitral valve disease
Beyond the preview
Go deeper on PACTR202106565996138.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202106565996138.